Since prior research has identified CD56 as crucial markers for diagnosing, predicting, and monitoring plasma cell disorders (4), the absence of CD56 expression was used as an indicator of the depletion of abnormal plasma cells. This evidence concerns the gene NCAM1 and plasma cell neoplasm.